Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model.
Kidney Int
; 99(1): 161-172, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-32898569
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Graft Rejection
/
Graft Survival
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Kidney Int
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos